CVS Health Corp.

CVS Health Corp.

CVSNYSEHealthcare
$92.36
down -0.22 (-0.24%)

1-Year Price

+20.15% past year
CVS Health Corp. (CVS) 1-year price chart: up 20.15% from $76.87 on Oct 2025 to $92.36 on Oct 2026. Closing range $70.08 to $110.60.

EquityGlimpse Score

Overall
4.5/10
No Moat

No clear sustainable competitive advantage detected.

Growth
2
Sign up free to see the full breakdown

Valuation, profitability, financial health, dividend and sentiment scores for CVS Health Corp. (CVS) are available to EquityGlimpse members.

Market Cap
118.13B
P/E Ratio
56.69
EPS
$1.40
52W High
$110.68
52W Low
$69.51
Volume
6.98M
Beta
0.6
Dividend Yield
3.38%
Fair value estimate: sign up to see
Is CVS over- or undervalued? Run DCF and multiples models on EquityGlimpse.
See fair value

Key Financial Metrics

Price to Sales
0.25
Price to Book
1.34
EV/EBITDA
18.82
Free CF per Share
$6.16
Op. CF per Share
$8.40
Debt to Equity
1.24
Gross Margin
13.77%
Net Margin
0.44%

About CVS Health Corp.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CEO
J. David Joyner
Industry
Medical - Healthcare Plans
Employees
259,500
IPO Date
1973-02-21
Country
US
Website
cvshealth.com
Unlock Full Analysis

Get the complete picture on CVS Health Corp.

Sign up for EquityGlimpse to access deep fundamental data, AI reports, valuation models, and real-time tracking for CVS and 8,500+ other stocks.

30 Years of Financials
Income statements, balance sheets, and cash flows with 70+ interactive charts
AI-Powered Analysis
Generate professional research reports with 15+ AI models
DCF Valuation
Run discounted cash flow models with customizable assumptions
Portfolio Tracking
Track real-time P&L, sector allocation, and dividend projections
Earnings Intelligence
Surprise tracking, revision momentum, and whisper estimates
Insider & Congress Trades
Monitor what insiders and Congress members are buying and selling
Start 7-Day Free Trial View Pricing

Starting at $8.25/month. 7-day free trial. Cancel anytime.